PDS Biotechnology Corporation (PDSB) Financials
PDSB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 24.7 billion | 20.8 billion |
| Dec. 31, 2025 | 30.5 million | 21.2 million |
| Sept. 30, 2025 | 34.7 million | 25.3 million |
| June 30, 2025 | 40.5 million | 24.5 million |
PDSB Free Cash Flow and Stock based compensation
No data available :(
PDSB Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | -7.3 million |
| Dec. 31, 2025 | 18.8 billion |
| Sept. 30, 2025 | -9.0 million |
| June 30, 2025 | -9.4 million |
PDSB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 21.7 billion | 17.7 million | 48655 |
| Dec. 31, 2025 | 26.7 million | 11.7 million | 25686 |
| Sept. 30, 2025 | 26.2 million | 11.9 million | 33517 |
| June 30, 2025 | 31.9 million | 12.9 million | 93110 |
PDSB Shares Outstanding
PDSB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 3.5 million | 3.1 billion | - |
| Dec. 31, 2025 | 5 | 4.4 million | 2.3 million | - |
| Sept. 30, 2025 | - | 4.6 million | 3.6 million | - |
| June 30, 2025 | 3 | 4.2 million | 3.4 million | - |
PDSB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 15131 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 15129 |
PDSB
Price: $0.96
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 392200
Market Capitalization: 56.9 million